12-Month Price Target For Adaptive Biotechnologies Corp (NASDAQ:ADPT) Now Sits At 18
In last trading session, Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw 2.45 million shares changing hands with its beta currently measuring 1.72. Company’s recent per share price